Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study.

Cotte L, Ferry T, Pugliese P, Valantin MA, Allavena C, Cabié A, Poizot-Martin I, Rey D, Duvivier C, Cheret A, Dellamonica P, Pradat P, Parienti JJ; Dat’AIDS study group..

PLoS One. 2017 Feb 2;12(2):e0170661. doi: 10.1371/journal.pone.0170661. eCollection 2017.

2.

Simplification of HAART therapy on ambulatory HIV patients in Malaysia:a randomized controlled trial.

Velvanathan T, Islahudin F, Sim BL, Taha NA.

Pharm Pract (Granada). 2016 Oct-Dec;14(4):830. doi: 10.18549/PharmPract.2016.04.830. Epub 2016 Dec 15.

3.

Barriers to HIV Medication Adherence as a Function of Regimen Simplification.

Chen Y, Chen K, Kalichman SC.

Ann Behav Med. 2017 Feb;51(1):67-78. doi: 10.1007/s12160-016-9827-3.

PMID:
27510955
4.

Patients' Willingness to Take Multiple-Tablet Antiretroviral Therapy Regimens for Treatment of HIV.

Engelhard EA, Smit C, Vervoort SC, Smit PJ, Nieuwkerk PT, Kroon FP, Reiss P, Brinkman K, Geerlings SE.

Drugs Real World Outcomes. 2016 May 2;3(2):223-230. eCollection 2016 Jun.

5.

Treatment Outcomes and Resistance Patterns of Children and Adolescents on Second-Line Antiretroviral Therapy in Asia.

Prasitsuebsai W, Teeraananchai S, Singtoroj T, Truong KH, Ananworanich J, Do VC, Nguyen LV, Kosalaraksa P, Kurniati N, Sudjaritruk T, Chokephaibulkit K, Kerr SJ, Sohn AH.

J Acquir Immune Defic Syndr. 2016 Aug 1;72(4):380-6. doi: 10.1097/QAI.0000000000000971.

PMID:
27355415
6.

Facilitators and barriers to antiretroviral therapy adherence among adolescents in Ghana.

Ankrah DN, Koster ES, Mantel-Teeuwisse AK, Arhinful DK, Agyepong IA, Lartey M.

Patient Prefer Adherence. 2016 Mar 15;10:329-37. doi: 10.2147/PPA.S96691. eCollection 2016.

7.

Antiretroviral therapy adherence strategies used by patients of a large HIV clinic in Lesotho.

Axelsson JM, Hallager S, Barfod TS.

J Health Popul Nutr. 2015 Aug 6;33:10. doi: 10.1186/s41043-015-0026-9.

9.

HIV treatment and care among Italian inmates: a one-month point survey.

Monarca R, Madeddu G, Ranieri R, Carbonara S, Leo G, Sardo M, Choroma F, Casari S, Marri D, Muredda AA, Nava FA, Babudieri S; SIMSPe–SIMIT Group..

BMC Infect Dis. 2015 Dec 10;15:562. doi: 10.1186/s12879-015-1301-5.

10.

Meta-Analysis of Studies Comparing Single and Multi-Tablet Fixed Dose Combination HIV Treatment Regimens.

Clay PG, Nag S, Graham CM, Narayanan S.

Medicine (Baltimore). 2015 Oct;94(42):e1677. doi: 10.1097/MD.0000000000001677.

11.

Prevalence of Transmitted HIV Drug Resistance Among Recently Infected Persons in San Diego, CA 1996-2013.

Panichsillapakit T, Smith DM, Wertheim JO, Richman DD, Little SJ, Mehta SR.

J Acquir Immune Defic Syndr. 2016 Feb 1;71(2):228-36. doi: 10.1097/QAI.0000000000000831.

12.

Efficacy, safety, and patient acceptability of elvitegravir/cobicistat/emtricitabine/tenofovir in the treatment of HIV/AIDS.

Prinapori R, Di Biagio A.

Patient Prefer Adherence. 2015 Aug 24;9:1213-8. doi: 10.2147/PPA.S88490. eCollection 2015. Review.

13.

Perampanel in the management of partial-onset seizures: a review of safety, efficacy, and patient acceptability.

Schulze-Bonhage A, Hintz M.

Patient Prefer Adherence. 2015 Aug 11;9:1143-51. doi: 10.2147/PPA.S63951. eCollection 2015. Review.

14.

A Review of the Toxicity of HIV Medications II: Interactions with Drugs and Complementary and Alternative Medicine Products.

Stolbach A, Paziana K, Heverling H, Pham P.

J Med Toxicol. 2015 Sep;11(3):326-41. doi: 10.1007/s13181-015-0465-0. Review.

15.

Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation.

Maggiolo F, Colombo GL, Di Matteo S, Bruno GM, Astuti N, Di Filippo E, Masini G, Bernardini C.

Patient Relat Outcome Meas. 2015 Feb 17;6:53-60. doi: 10.2147/PROM.S63586. eCollection 2015.

16.

The role of dolutegravir in the management of HIV infection.

Miller MM, Liedtke MD, Lockhart SM, Rathbun RC.

Infect Drug Resist. 2015 Feb 19;8:19-29. doi: 10.2147/IDR.S58706. eCollection 2015. Review.

17.

The Effect on Treatment Adherence of Administering Drugs as Fixed-Dose Combinations versus as Separate Pills: Systematic Review and Meta-Analysis.

van Galen KA, Nellen JF, Nieuwkerk PT.

AIDS Res Treat. 2014;2014:967073. doi: 10.1155/2014/967073. Epub 2014 Sep 4. Review.

18.

Single-Tablet Regimens in HIV Therapy.

Astuti N, Maggiolo F.

Infect Dis Ther. 2014 Jun;3(1):1-17. doi: 10.1007/s40121-014-0024-z. Epub 2014 Feb 20.

19.

Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe.

Frentz D, Van de Vijver DA, Abecasis AB, Albert J, Hamouda O, Jørgensen LB, Kücherer C, Struck D, Schmit JC, Vercauteren J, Åsjö B, Balotta C, Beshkov D, Camacho RJ, Clotet B, Coughlan S, Griskevicius A, Grossman Z, Horban A, Kolupajeva T, Korn K, Kostrikis LG, Liitsola K, Linka M, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M, Puchhammer-Stöckl E, Sönnerborg A, Stanekova D, Stanojevic M, Van Wijngaerden E, Wensing AM, Boucher CA; SPREAD Programme..

BMC Infect Dis. 2014 Jul 21;14:407. doi: 10.1186/1471-2334-14-407.

20.

Women, Aging, and HIV: Clinical Issues and Management Strategies.

Womack JA, Brandt CA, Justice AC.

J Nurse Pract. 2014 Jun 1;10(6):409-416.

Supplemental Content

Support Center